924. Adulteration  and misbranding of Azamine  Capsules.    IT.  S. v. 4 Boxes  of
Azamlne   Capsules.    Default  decree   of  condemnation.    Product  ordered
destroyed.    (F. D. C. No. 8018.    Sample No. 7216-F.)
This product contained the active ingredient in excess of the amount declared
on the label, and it would not be an effective treatment for various disease con-
ditions for which it was recommended in the labeling.
On July 31, 1942, the United States attorney for the Eastern District of Wis-
consin filed a libel at Milwaukee, Wis., against 4 boxes of Azamine Capsules,
alleging that the article had been shipped in interstate commerce on or about
June 8, 1942, by the Nepera Chemical Co., Inc., from Tonkers, N. Y.
Analysis of a sample of the article showed that each capsule contained not
less than 5.89 grams (90.9 grains) of tolyl azo diamino pyridine hydrochloride.
It was alleged to be adulterated in that its strength differed from that which
it purported and was represented to possess.
It was alleged to be misbranded in that the statement "5 Grams * * *
Each capsule contains 5 grams (77.2 grs. app.) of Tolyl-Azo-Diamino-Pyridine-
Hydrochloride," borne on the label, was false and misleading.
The article was also alleged to be misbranded in that statements made in the
labeling which represented and suggested that it was effective in the treatment
of various disease conditions were false and misleading since it was not
effective for these conditions. Some of the representations made were that
Azamine has been shown to possess marked bactericidal power in coccal and B.
coli infections, and that it was an antiseptic of proved value in a wide range
of infections in large and small animals. It was recommended for mastitis,
metritis, vesicular vaginitis, urinary infections, necrotic lesions, sinuses and
fistulae, as well as for acute septic metritis, cystitis, nephritis, coccidiosis, gas-
tritis, enteritis, septicemia and pyemia. It was also recommended as a topical
application for udder and teat injuries, keratitis, conjunctivitis, and traumata of
eye and associated tissues.
On October 1, 1942, no claimant having appeared, judgment of condemnation
was entered and the product was ordered destroyed.